DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Taxotere (Docetaxel) - Current Clinical Trials


Taxotere Related Clinical Trials

Pharmacokinetic Study of CKD-810 and Taxotere to Treat Patient With Advanced Solid Cancer [Completed]

Taxotere and Adriamycin/Cytoxan (AC) Validation in Breast Cancer Patients [Recruiting]

Biomarker Study for Sunitinib and Docetaxel in Prostate Cancer [Recruiting]

Extension Neoadjuvant Taxotere: Study of the Effects of Taxotere in Patients With Breast Cancer [Terminated]

Study to Evaluate Combination Treatment of MGCD0103 and Docetaxel (Taxotere®) for Subjects With Advanced Cancer Tumors [Terminated]

Randomized Study of Docetaxel +/- ZD6474 in Metastatic TCC [Completed]

Study of Usefulness of Genotyping to Predict Docetaxel Exposure and Adverse Events [Completed]

A Multiple-Dose Study of RhuMab 2C4 and Docetaxel in the Treatment of Advanced Solid Tumors [Completed]

TaxoteRe Plus Cisplatin Versus AlImta Plus Cisplatin in 1st Line Non-squamous Cell Type Lung Cancer [Terminated]

Biologic Correlative Taxotere/AC [Completed]

Docetaxel and Trastuzumab With or Without Carboplatin in Treating Women With HER2-Positive Breast Cancer [Completed]

Feasibility of a Chemotherapy With Docetaxel-Prednisone for Castration-resistant Metastatic Prostate Cancer Elderly Patients [Recruiting]

Preoperative Herceptin/Navelbine Versus Taxotere/Carboplatin/Herceptin in HER-2 Positive Breast Cancer [Completed]

A Study of Gemzar, Taxotere, and Xeloda for Adjuvant Pancreatic Cancer [Completed]

RAD001 Plus Docetaxel in Patients With Metastatic Breast Cancer [Terminated]

The Effects Of GW679769 (Casopitant) On The Pharmacokinetics Of Docetaxel In Subjects With Cancer [Completed]

Phase II: RAD001 Plus Docetaxel in Patients With Metastatic Breast Cancer [Withdrawn]

Iressa and Taxotere Study in Patients With Metastatic Urothelial Cancer [Completed]

Phase II Study of Docetaxel for Clinically Asymptomatic High Risk Prostate Cancer Patients [Terminated]

Induction Study of Cisplatin, Docetaxel, and Nintedanib Stage IB-IIIA Non-Small Cell Lung Cancer (NCLC) [Recruiting]

Randomized, Multi-center, Open-label, Study of PR104 Versus PR104/Docetaxel in Non-Small Cell Lung Cancer (NSCLC) [Terminated]

OSI-774/Cisplatin/Taxotere in Head & Neck Squamous Cell Cancer [Active, not recruiting]

Docetaxel Lipid Microsphere (DT-LM) for Injection in Chemotherapy Patients [Recruiting]

Phase 1/2 Study of Vascular Disrupting Agent NPI-2358 + Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer [Completed]

Docetaxel (Taxotere), Vinorelbine, and Bevacizumab, as Adjuvant Chemotherapy for Patients With Resected Stage I-III Non-small Cell Lung Cancer [Completed]

A Study of the Efficacy and Safety of Trastuzumab Emtansine (Trastuzumab-MCC-DM1) vs. Trastuzumab (Herceptin®) and Docetaxel (Taxotere®) in Patients With Metastatic HER2-positive Breast Cancer Who Have Not Received Prior Chemotherapy for Metastatic Disease [Completed]

Docetaxel+Oxali+/-Cetux Met Gastric/GEJ [Completed]

Study to Evaluate SID 530 Compared to Taxotere [Completed]

Carboplatin Plus Docetaxel (Taxotere) in Anaplastic Prostate Cancer [Completed]

Phase II Trial Comparing ABI-007 (Abraxane®, Nab®-Paclitaxel) to Taxotere in First Line Therapy of Patients With Stage IV Breast Cancer [Completed]

Trial With Taxotere and Cisplatin in Non-operable Adrenocortical Carcinoma [Completed]

Docetaxel and Lycopene in Metastatic Prostate Cancer [Recruiting]

Phase II Trial of Gleevec and Taxotere as a Combined Regimen for Advanced Gastric Adenocarcinoma [Terminated]

VEGF Trap and Docetaxel in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer [Completed]

Docetaxel With or Without AZD6244 in Melanoma [Active, not recruiting]

A Phase 1b Dose Escalation Trial of PSK®/Placebo With Docetaxel to Treat Metastatic Castration-resistant Prostate Cancer [Suspended]

Irinotecan and Taxotere With Radiotherapy as Preoperative Treatment in Resectable Esophageal Cancer [Completed]

Safety Study of a New Schedule of Capecitabine and Docetaxel to Treat Cancers [Completed]

A Phase 2 Study Evaluating ABT-751 in Combination With Taxotere in Advanced Non-Small Cell Lung Cancer [Terminated]

Study of Taxotere and Doxil to Treat Advanced Androgen-Independent Prostate Cancer [Completed]

Docetaxel Plus Lycopene in Castration Resistant, Chemotherapy-Na�ve Prostate Cancer Patients [Recruiting]

RAD001 (Everolimus) + Docetaxel + Cisplatin as Induction Chemotherapy in Patients With Local-Regional Advanced Head and Neck Cancer [Completed]

Trastuzumab (Herceptin), Bevacizumab, and Docetaxel (Taxotere) Trial in Stage IV Metastatic Breast Cancer (MBC) Patients [Active, not recruiting]

Study of PX-866 and Docetaxel in Solid Tumors [Completed]

Taxotere, Cisplatin, and CPT-11 in Advanced Solid Tumor Malignancies [Completed]

Docetaxel, Radiation Therapy, and Prednisone in Treating Patients Who Have Undergone Surgery For Prostate Cancer [Active, not recruiting]

Taxotere/Temodar/Cisplatin Study in Melanoma Patients [Completed]

Taxotere, Cisplatin and Irinotecan (CPT-11) for Esophagogastric Cancer [Completed]

Irinotecan and Docetaxel With or Without Cetuximab in Treating Patients With Metastatic Pancreatic Cancer [Completed]

Docetaxel/Carboplatin Versus Docetaxel/Caelyx in Pretreated Patients With Ovarian Carcinoma [Withdrawn]

A Phase II Study of Docetaxel Plus Carboplatin in Chemonaive Hormone-Refractory Prostate Cancer (HRPC) Patients [Completed]

Study of Taxotere, Cisplatin, 5-Fluorouracil, and Leucovorin for Squamous Cell Carcinoma of the Head and Neck [Completed]

Sublingual Anvirzel in Advance Non-Small Cell Lung Cancer (NSCLC) [Withdrawn]

Observational Study of Docetaxel Exposure in Metastatic Prostate Cancer Patients [Recruiting]

A Phase 1b/2, Study of Pegylated Recombinant Human Hyaluronidase Combined With Docetaxel Versus Docetaxel Alone in Subjects With Recurrent Previously Treated Locally Advanced or Metastatic NSCLC. [Recruiting]

Erlotinib and Docetaxel With Concomitant Boost Radiation Therapy (XRT) for Head and Neck Squamous Cell Carcinoma (HNSCC) [Completed]

Primary Chemotherapy With Docetaxel-Capecitabine and Doxorubicin-Cyclophosphamide in Breast Cancer [Completed]

Docetaxel With or Without Ascorbic Acid in Treating Patients With Metastatic Prostate Cancer [Not yet recruiting]

Celecoxib and Docetaxel in Treating Patients With Non-Small Cell Lung Cancer [Completed]

Cisplatin and Docetaxel Plus Docetaxel and Radiotherapy With Amifostine for Squamous Cell Carcinoma of the Head and Neck [Completed]

Imatinib Mesylate and Docetaxel in Non-Small Cell Lung Cancer (NSCLC) [Completed]

Hormonal Ablation, Imatinib Mesylate and Docetaxel for Patients With Prostate Cancer [Completed]

Study of Gemzar®, Taxotere®, and Xeloda® (GTX) in Patients With Metastatic Pancreatic Cancer (Stage IVB) [Completed]

Docetaxel and Imatinib Mesylate in Treating Patients With Locally Advanced or Metastatic Breast Cancer [Completed]

Phase III Trial Of Docetaxel Versus Docetaxel Plus ZD1839 In Head And Neck Cancer [Terminated]

BIBF 1120 + Docetaxel (Japan) in Patients With Advanced Non-small-cell Lung Cancer, Phase I [Active, not recruiting]

Phase I Study of IPI-504 and Docetaxel in Patients With Advanced Solid Tumors [Completed]

A Double-blind Study Evaluating IPI-504 and Docetaxel in Patients With Non-Small Cell Lung Cancer [Completed]

Phase 2 Study of EC145 Alone Versus EC145+Docetaxel Versus Docetaxel Alone in Participants With FR(++) 2nd Line Non Small Cell Lung Cancer [Completed]

Therapy With Docetaxel and ZD1839 for Patients Who Have Advanced Breast Cancer [Completed]

Neoadjuvant Taxotere [Completed]

Trial of Eribulin/Cyclophosphamide or Docetaxel/Cyclophosphamide as Neoadjuvant Therapy in Locally Advanced HER2-Negative Breast Cancer [Active, not recruiting]

Study Comparing Concomitant Docetaxel + Gemcitabine to Sequential Therapy of Docetaxel Followed by Gemcitabine [Completed]

Binimetinib With Docetaxel in Treating Patients With Previously Treated, Stage IV Non-small Cell Lung Cancer [Not yet recruiting]

Imatinib Mesylate (Gleevec) and Docetaxel in Patients With Head and Neck Squamous Cell Cancer [Completed]

Genetic Expression and Prediction of Response to Neoadjuvant Docetaxel or Doxorubicin in Locally Advanced Breast Cancer [Completed]

Dose-Dense Docetaxel Before or After Doxorubicin/Cyclophosphamide in Axillary Node-Positive Breast Cancer [Completed]

Carboplatin and Paclitaxel With or Without Bevacizumab Compared to Docetaxel, Carboplatin, and Paclitaxel in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Carcinoma (Cancer) [Completed]

Study Of SU011248 In Combination With Docetaxel And Trastuzumab In Patients With Advanced Breast Cancer HER-2 Positive [Completed]

VEGFR/PDGFR Dual Kinase Inhibitor X-82 and Docetaxel in Treating Patients With Solid Tumors [Recruiting]

Pazopanib, Docetaxel, Prednisone Prostate [Active, not recruiting]

Docetaxel and Sirolimus in Patients With Advanced Malignancies [Completed]

TaxXel: Taxotere and Xeloda in Esophageal Cancer [Active, not recruiting]

Study of BMS-936558 (Nivolumab) Compared to Docetaxel in Previously Treated Advanced or Metastatic Squamous Cell Non-small Cell Lung Cancer (NSCLC) (CheckMate 017) [Active, not recruiting]

Safety Profile, MTD, and PK Profile Studies of ABT-263 When Administered in Combination With Standard and Weekly Regimens of Docetaxel in Subjects With Cancer [Completed]

Trial of Weekly Taxotere and Irinotecan (CPT-11) in Patients With Advanced Non-small Cell Lung Cancer [Completed]

A Study Of PF-05280014 Or Trastuzumab Plus Taxotere® And Carboplatin In HER2 Positive Breast Cancer In The Neoadjuvant Setting (REFLECTIONS B327-04) [Recruiting]

Target Dosing of Docetaxel Through Pharmacokinetic/Pharmacodynamic Optimisation of the First Chemotherapeutic Cycle [Completed]

Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design [Recruiting]

Randomized Phase III Trial With Docetaxel Plus Epirubicine Versus Docetaxel Plus Capecitabine for Metastatic Breast Cancer [Completed]

Phase I Study of LB-100 With Docetaxel in Solid Tumors [Recruiting]

The Pharmacokinetics and Safety Characteristics of Docetaxel in Patients With Cancer [Completed]

Safety and Efficacy Study of GM-CSF, Thalidomide Plus Docetaxel in Prostate Cancer [Terminated]

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017